Shanghai, China · Founded 2019 · Privately Held (backing)
Developer of small-molecule innovative therapeutics intended for the treatment of autoimmune and tumor diseases. LeadingTac is based in Shanghai, China and was founded in 2019. Its last reported valuation was $8.5 million in Nov 2019. It has raised $63.8 million.
Last reported valuation
$8.5M
Oct 2026
Priced at
—
Total raised
$63.8M
Last round
—
Cap table — not yet on record
LeadingTac's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of LeadingTac with a free account
·Watch LeadingTac: the Monday email on marks, rounds and moves
